BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9764889)

  • 1. Renal impairment in patients with long-standing cyanotic congenital heart disease.
    Dittrich S; Haas NA; Bührer C; Müller C; Dähnert I; Lange PE
    Acta Paediatr; 1998 Sep; 87(9):949-54. PubMed ID: 9764889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal involvement in patients with congenital cyanotic heart disease.
    Krull F; Ehrich JH; Wurster U; Toel U; Rothgänger S; Luhmer I
    Acta Paediatr Scand; 1991 Dec; 80(12):1214-9. PubMed ID: 1785294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular and tubular dysfunction in children with congenital cyanotic heart disease: effect of palliative surgery.
    Awad H; el-Safty I; Abdel-Gawad M; el-Said S
    Am J Med Sci; 2003 Mar; 325(3):110-4. PubMed ID: 12640285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.
    Hongsawong N; Khamdee P; Silvilairat S; Chartapisak W
    Pediatr Nephrol; 2018 Mar; 33(3):493-501. PubMed ID: 28971258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanotic nephropathy and use of non-ionic contrast agents during cardiac catherization in patients with cyanotic congenital heart disease.
    Dittrich S; Kurschat K; Dähnert I; Vogel M; Müller C; Lange PE
    Cardiol Young; 2000 Jan; 10(1):8-14. PubMed ID: 10695534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor.
    Fujimoto Y; Matsushima M; Tsuzuki K; Okada M; Shibata M; Yanase Y; Usui K; Nagashima M
    Clin Nephrol; 2002 Aug; 58(2):95-102. PubMed ID: 12227694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease.
    Dittrich S; Kurschat K; Dähnert I; Vogel M; Müller C; Alexi-Meskishvili V; Lange PE
    Int J Cardiol; 2000 Apr; 73(2):173-9. PubMed ID: 10817857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephropathy in patients with cyanotic congenital heart disease.
    Akita H; Matsuoka S; Kuroda Y
    Tokushima J Exp Med; 1993 Jun; 40(1-2):47-53. PubMed ID: 8211980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanotic nephropathy--a morphometric analysis.
    Gupte PA; Vaideeswar P; Kandalkar BM
    Congenit Heart Dis; 2014; 9(4):280-5. PubMed ID: 23834022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and 24-hour urine analysis in adult cyanotic and noncyanotic congenital heart disease patients.
    Martínez-Quintana E; Rodríguez-González F; Fábregas-Brouard M; Nieto-Lago V
    Congenit Heart Dis; 2009; 4(3):147-52. PubMed ID: 19489941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of development and progression of cyanotic nephropathy.
    Inatomi J; Matsuoka K; Fujimaru R; Nakagawa A; Iijima K
    Pediatr Nephrol; 2006 Oct; 21(10):1440-5. PubMed ID: 16902784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function in cyanotic congenital heart disease.
    Burlet A; Drukker A; Guignard JP
    Nephron; 1999; 81(3):296-300. PubMed ID: 10050084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal rheology in cyanotic congenital heart disease--a factor in non-immune nephropathy.
    Dittrich S; Kurschat K; Lange PE
    Scand J Urol Nephrol; 2001 Oct; 35(5):411-5. PubMed ID: 11771869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal renal functions in cyanotic congential heart disease.
    Passwell J; Orda S; Modan M; Shem-Tov A; Aladjem A; Boichis H
    Arch Dis Child; 1976 Oct; 51(10):803-5. PubMed ID: 1008586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of renal function between cyanotic and acyanotic congenital heart disease in children and adolescent.
    Amornchaicharoensuk Y; Werawatganon T; Tohsukhowong P; Boonla C; Gengsakul A; Tarunotai T; Samankatiwat P; Treewatchareekorn M
    J Med Assoc Thai; 2012 Dec; 95(12):1501-8. PubMed ID: 23390779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease.
    Jensen AS; Johansson PI; Idorn L; Sørensen KE; Thilén U; Nagy E; Furenäs E; Søndergaard L
    Int J Cardiol; 2013 Aug; 167(4):1317-21. PubMed ID: 22578951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic syndrome complicating cyanotic congenital heart disease: a report of two cases.
    Ogunkunle OO; Asinobi AO; Omokhodion SI; Ademola AD
    West Afr J Med; 2008 Oct; 27(4):263-6. PubMed ID: 19469408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the glomerular lesions of cyanotic congenital heart disease.
    Spear GS
    J Chronic Dis; 1966 Oct; 19(10):1083-8. PubMed ID: 5338341
    [No Abstract]   [Full Text] [Related]  

  • 19. Glomerulomegaly in a patient with cyanotic congenital heart disease.
    Ingelfinger JR; Kissane JM; Robson AM
    Am J Dis Child; 1970 Jul; 120(1):69-71. PubMed ID: 5422860
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease.
    Jensen AS; Johansson PI; Bochsen L; Idorn L; Sørensen KE; Thilén U; Nagy E; Furenäs E; Søndergaard L
    Int J Cardiol; 2013 Sep; 167(5):2210-4. PubMed ID: 22727966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.